Cargando…
High Prevalence of Cysticercosis in People with Epilepsy in Southern Rwanda
BACKGROUND: Neurocysticercosis (NCC), the central nervous system infection by Taenia solium larvae, is a preventable and treatable cause of epilepsy. In Sub-Saharan Africa, the role of NCC in epilepsy differs geographically and, overall, is poorly defined. We aimed at contributing specific, first da...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828157/ https://www.ncbi.nlm.nih.gov/pubmed/24244783 http://dx.doi.org/10.1371/journal.pntd.0002558 |
_version_ | 1782291189892907008 |
---|---|
author | Rottbeck, Ruth Nshimiyimana, Jules Fidèle Tugirimana, Pierrot Düll, Uta E. Sattler, Janko Hategekimana, Jean-Claudien Hitayezu, Janvier Bruckmaier, Irmengard Borchert, Matthias Gahutu, Jean Bosco Dieckmann, Sebastian Harms, Gundel Mockenhaupt, Frank P. Ignatius, Ralf |
author_facet | Rottbeck, Ruth Nshimiyimana, Jules Fidèle Tugirimana, Pierrot Düll, Uta E. Sattler, Janko Hategekimana, Jean-Claudien Hitayezu, Janvier Bruckmaier, Irmengard Borchert, Matthias Gahutu, Jean Bosco Dieckmann, Sebastian Harms, Gundel Mockenhaupt, Frank P. Ignatius, Ralf |
author_sort | Rottbeck, Ruth |
collection | PubMed |
description | BACKGROUND: Neurocysticercosis (NCC), the central nervous system infection by Taenia solium larvae, is a preventable and treatable cause of epilepsy. In Sub-Saharan Africa, the role of NCC in epilepsy differs geographically and, overall, is poorly defined. We aimed at contributing specific, first data for Rwanda, assessing factors associated with NCC, and evaluating a real-time PCR assay to diagnose NCC in cerebrospinal fluid (CSF). METHODOLOGY/PRINCIPAL FINDINGS: At three healthcare facilities in southern Rwanda, 215 people with epilepsy (PWE) and 51 controls were clinically examined, interviewed, and tested by immunoblot for cysticerci-specific serum antibodies. Additionally, CSF samples from PWE were tested for anticysticercal antibodies by ELISA and for parasite DNA by PCR. Cranial computer tomography (CT) scans were available for 12.1% of PWE with additional symptoms suggestive of NCC. The Del Brutto criteria were applied for NCC diagnosis. Cysticerci-specific serum antibodies were found in 21.8% of PWE and 4% of controls (odds ratio (OR), 6.69; 95% confidence interval (95%CI), 1.6–58.7). Seropositivity was associated with age and lack of safe drinking water. Fifty (23.3%) PWE were considered NCC cases (definitive, based on CT scans, 7.4%; probable, mainly based on positive immunoblots, 15.8%). In CSF samples from NCC cases, anticysticercal antibodies were detected in 10% (definitive cases, 25%) and parasite DNA in 16% (definitive cases, 44%). Immunoblot-positive PWE were older (medians, 30 vs. 22 years), more frequently had late-onset epilepsy (at age >25 years; 43.5% vs. 8.5%; OR, 8.30; 95%CI, 3.5–20.0), and suffered from significantly fewer episodes of seizures in the preceding six months than immunoblot-negative PWE. CONCLUSIONS/SIGNIFICANCE: NCC is present and contributes to epilepsy in southern Rwanda. Systematic investigations into porcine and human cysticercosis as well as health education and hygiene measures for T. solium control are needed. PCR might provide an additional, highly specific tool in NCC diagnosis. |
format | Online Article Text |
id | pubmed-3828157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-38281572013-11-16 High Prevalence of Cysticercosis in People with Epilepsy in Southern Rwanda Rottbeck, Ruth Nshimiyimana, Jules Fidèle Tugirimana, Pierrot Düll, Uta E. Sattler, Janko Hategekimana, Jean-Claudien Hitayezu, Janvier Bruckmaier, Irmengard Borchert, Matthias Gahutu, Jean Bosco Dieckmann, Sebastian Harms, Gundel Mockenhaupt, Frank P. Ignatius, Ralf PLoS Negl Trop Dis Research Article BACKGROUND: Neurocysticercosis (NCC), the central nervous system infection by Taenia solium larvae, is a preventable and treatable cause of epilepsy. In Sub-Saharan Africa, the role of NCC in epilepsy differs geographically and, overall, is poorly defined. We aimed at contributing specific, first data for Rwanda, assessing factors associated with NCC, and evaluating a real-time PCR assay to diagnose NCC in cerebrospinal fluid (CSF). METHODOLOGY/PRINCIPAL FINDINGS: At three healthcare facilities in southern Rwanda, 215 people with epilepsy (PWE) and 51 controls were clinically examined, interviewed, and tested by immunoblot for cysticerci-specific serum antibodies. Additionally, CSF samples from PWE were tested for anticysticercal antibodies by ELISA and for parasite DNA by PCR. Cranial computer tomography (CT) scans were available for 12.1% of PWE with additional symptoms suggestive of NCC. The Del Brutto criteria were applied for NCC diagnosis. Cysticerci-specific serum antibodies were found in 21.8% of PWE and 4% of controls (odds ratio (OR), 6.69; 95% confidence interval (95%CI), 1.6–58.7). Seropositivity was associated with age and lack of safe drinking water. Fifty (23.3%) PWE were considered NCC cases (definitive, based on CT scans, 7.4%; probable, mainly based on positive immunoblots, 15.8%). In CSF samples from NCC cases, anticysticercal antibodies were detected in 10% (definitive cases, 25%) and parasite DNA in 16% (definitive cases, 44%). Immunoblot-positive PWE were older (medians, 30 vs. 22 years), more frequently had late-onset epilepsy (at age >25 years; 43.5% vs. 8.5%; OR, 8.30; 95%CI, 3.5–20.0), and suffered from significantly fewer episodes of seizures in the preceding six months than immunoblot-negative PWE. CONCLUSIONS/SIGNIFICANCE: NCC is present and contributes to epilepsy in southern Rwanda. Systematic investigations into porcine and human cysticercosis as well as health education and hygiene measures for T. solium control are needed. PCR might provide an additional, highly specific tool in NCC diagnosis. Public Library of Science 2013-11-14 /pmc/articles/PMC3828157/ /pubmed/24244783 http://dx.doi.org/10.1371/journal.pntd.0002558 Text en © 2013 Rottbeck et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Rottbeck, Ruth Nshimiyimana, Jules Fidèle Tugirimana, Pierrot Düll, Uta E. Sattler, Janko Hategekimana, Jean-Claudien Hitayezu, Janvier Bruckmaier, Irmengard Borchert, Matthias Gahutu, Jean Bosco Dieckmann, Sebastian Harms, Gundel Mockenhaupt, Frank P. Ignatius, Ralf High Prevalence of Cysticercosis in People with Epilepsy in Southern Rwanda |
title | High Prevalence of Cysticercosis in People with Epilepsy in Southern Rwanda |
title_full | High Prevalence of Cysticercosis in People with Epilepsy in Southern Rwanda |
title_fullStr | High Prevalence of Cysticercosis in People with Epilepsy in Southern Rwanda |
title_full_unstemmed | High Prevalence of Cysticercosis in People with Epilepsy in Southern Rwanda |
title_short | High Prevalence of Cysticercosis in People with Epilepsy in Southern Rwanda |
title_sort | high prevalence of cysticercosis in people with epilepsy in southern rwanda |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828157/ https://www.ncbi.nlm.nih.gov/pubmed/24244783 http://dx.doi.org/10.1371/journal.pntd.0002558 |
work_keys_str_mv | AT rottbeckruth highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda AT nshimiyimanajulesfidele highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda AT tugirimanapierrot highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda AT dullutae highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda AT sattlerjanko highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda AT hategekimanajeanclaudien highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda AT hitayezujanvier highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda AT bruckmaierirmengard highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda AT borchertmatthias highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda AT gahutujeanbosco highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda AT dieckmannsebastian highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda AT harmsgundel highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda AT mockenhauptfrankp highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda AT ignatiusralf highprevalenceofcysticercosisinpeoplewithepilepsyinsouthernrwanda |